Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CYCLOBENZAPRINE Cause Hypersensitivity? 614 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 614 reports of Hypersensitivity have been filed in association with CYCLOBENZAPRINE (Cyclobenzaprine hydrochloride). This represents 6.7% of all adverse event reports for CYCLOBENZAPRINE.

614
Reports of Hypersensitivity with CYCLOBENZAPRINE
6.7%
of all CYCLOBENZAPRINE reports
164
Deaths
71
Hospitalizations

How Dangerous Is Hypersensitivity From CYCLOBENZAPRINE?

Of the 614 reports, 164 (26.7%) resulted in death, 71 (11.6%) required hospitalization, and 66 (10.7%) were considered life-threatening.

Is Hypersensitivity Listed in the Official Label?

Yes, Hypersensitivity is listed as a known adverse reaction in the official FDA drug label for CYCLOBENZAPRINE.

What Other Side Effects Does CYCLOBENZAPRINE Cause?

Toxicity to various agents (1,854) Pain (1,494) Completed suicide (1,438) Drug hypersensitivity (1,094) Constipation (1,057) Drug ineffective (954) Drug abuse (873) Off label use (800) Fall (796) Hypotension (769)

What Other Drugs Cause Hypersensitivity?

ETANERCEPT (10,846) ADALIMUMAB (10,641) METHOTREXATE (9,799) TOCILIZUMAB (9,076) ABATACEPT (8,945) INFLIXIMAB (8,519) RITUXIMAB (8,408) ADAPALENE (8,356) LEFLUNOMIDE (7,926) CERTOLIZUMAB PEGOL (7,353)

Which CYCLOBENZAPRINE Alternatives Have Lower Hypersensitivity Risk?

CYCLOBENZAPRINE vs CYCLOPENTOLATE CYCLOBENZAPRINE vs CYCLOPHOSPHAMIDE CYCLOBENZAPRINE vs CYCLOPHOSPHAMIDE FOR , USP CYCLOBENZAPRINE vs CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\RITUXIMAB\VINCRISTINE CYCLOBENZAPRINE vs CYCLOPHOSPHAMIDE\DOXORUBICIN\PREDNISONE\VINCRISTINE

Related Pages

CYCLOBENZAPRINE Full Profile All Hypersensitivity Reports All Drugs Causing Hypersensitivity CYCLOBENZAPRINE Demographics